FDA Investigator Vanessa Y Gelsey, PhD
Vanessa Y Gelsey, PhD has conducted inspections on 107 sites in 2 countries as of 27 Apr 2016. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
107
Last Inspection Date:
27 Apr 2016
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Canada
FDA Investigators that have inspected at least one site in common with Vanessa Y Gelsey, PhD:
Aaron J Poloni,
Abby M Miller,
Alan D Grupe,
Alexander M Kay,
Andrew "Drew" Haack, PhD,
Andrew K Haack, PhD,
Anita Narula, PhD,
Arie C Menachem,
Astrida B Mattson,
Ava M Bowman,
Barbara Janine Breithaupt,
Betsy C Galliher,
Brenda K Alford,
Brenda L Reihing,
Brent W Higgs,
Brian M Janelsins, PhD,
Bruce R Burrell,
Bryan Baker,
Camille Bennett Hoffman,
Carl A Anderson,
CDR Donald Ertel,
Ce'nedra M Martin,
Celeta S Coves,
Charles Yuanchia Kuo, PhD,
Chava Kimchi Sarfaty, PhD,
Chet A Fitzgerald,
Christopher R Czajka,
Christopher S Genther,
Clint R Van Blaricom,
Colleen F Hoyt,
Cynthia L Gorveatt,
Cynthia L Rakestraw,
Dan G Eisenbrey,
Daniel A Congdon,
David A Quale,
Dawn E Barkans,
Deborah A Nebenzahl,
Deborah M Trout,
Dennis R Hudson,
Devon M Shoop,
Diane Hall,
Dianna D Wardlow Dotter,
Dirk L Lincoln,
Dolores E Price,
Edward D Harris,
Elmina E Akwo,
Eric C Milstead,
Gerard Pde Leon,
Gina C Collins,
Gloria A Milster,
Gloria J Baca, MS,
Harmon M Blanch,
Hasan A Irier, PhD,
Heika R Tait,
Hugh A Grimoldby,
Jane M Kreis,
Jean Brewer,
Jean C Colon Lopez,
Jean R Mccurry,
Jeanne M Weishaar,
Jeffrey N Gerdes,
Jessica B Clark,
Jessica L Kocian,
Jessica L Walters Moell,
Jessie J Deloach,
Jinkee Mvila Binayug,
Joan Johnson,
John W Banks,
Jonathan T Little,
Joseph A Dinardo,
Julian C Hanson,
Julie Scoma,
Kaarin M Slotte,
Karen M Cooper,
Katherine L Arnold,
Kathryn A Krentz,
Kathryn E King,
Kelly D Moore,
Kenneth O Gee, PhD,
Kimberly A Dux,
Kimberly Jproctor Jones,
Kip J Hanks,
Lance W Bohm,
Lauren E Swantko,
Lawrence Y Lee, PhD,
LCDR Ismael Olvera, IV,
Lee Terry Moore,
Linda S Leja,
Lisa A Bowden,
Lisa K Capron,
Lisa M Althar,
Lori J Silverstein,
LTJG Bradley E Benasutti,
Marc A Jackson, Jr,
Margaret M Annes,
Maria Pkelly Doggett, MBA,
Marijo B Kambere, PhD,
Mark E Imsland,
Mark E Moen,
Mark W Babbitt,
Marlene L Davis,
Marsha L Mccauley,
Matthew R Barr,
Michael J Donovan,
Michael S Araneta,
Michael S Valenzuela,
Mihaly S Ligmond,
Mikhail V Ovanesov, PhD,
Nancy A Saxenian Emmons,
Nancy E Byerly,
Nancy E Doyle,
Nataniel Phillips Sylvain, PhD,
Orval D Mcintire,
Ounchith J Phabmixay,
Paul F Rader,
Paul M Chefor,
Peter Kessler, PhD,
Peter W Gothro,
Philippe A Cornet,
Prabhu P Raju,
Rabia Ballica, PhD,
Ramon Lgonzalez Prieto,
Rebecca T Davis,
Richard A Martin,
Richard Heath Coats,
Richard Ledwidge (nmi), PhD,
Riley C Myers, PhD,
Robert B Shibuya, MD,
Robert D Tollefsen,
Rocco C Black,
Roger F Zabinski,
S Lori Brown, PhD MPH,
Sandra K Wangen,
Sangeeta M Khurana, PhD,
Sarah J Cullen,
Shahriar Rahmani,
Shannon J Hall,
Sharon I Gundersen,
Shelagh D Schopen,
Shelley H Beausoleil,
Sherri N Rohlf, MD,
Sherryl Stoltenow,
Sripal R Mada, PhD,
Stanley B Eugene, BS, BME,
Stephanie J Shaw,
Stephen R Souza,
Sunitha K Rajaram, PhD,
Tara A Marshall,
Teegan Dellibovi Ragheb, PhD,
Thomas C Mclean, CFS,
Thuy T Nguyen, LCDR,
Travis S Bradley,
V Teres Speer,
Vanessa Y Jacobs,
Veronica L Bush,
Vitaliy N Guyvan,
Wayne E Seifert,
Yideng Liang,
Yuan Chia Kuo,
Zhong Li, PhD
Vanessa Y Gelsey, PhD's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| September, 2013 | EIR | Biomat USA, Inc. - EIR, 2013-09-23 |
| June, 2012 | FDA 483 | International Cellular Medicine Society IRB - Form 483, 2012-06-19 |
| June, 2011 | FDA 483 Response | Snokist Growers - Form 483R, 2011-06-22 |
| June, 2011 | FDA 483 | Snokist Growers - Form 483, 2011-06-02 |
| April, 2016 | FDA 483 | AGC Biologics, Inc. - Form 483, 2016-04-22 |
| March, 2012 | FDA 483 | Arifulla Khan MD - Form 483, 2012-03-28 |
| September, 2013 | FDA 483 | Biomat USA, Inc. - Form 483, 2013-09-23 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more